한글목차

세계의 바이오 임플란트 시장은 2024년에 1,322억 4,000만 달러로 평가되었으며, 2030년까지 CAGR 10.85%로 성장하여 2,453억 2,000만 달러에 달할 것으로 예측됩니다.

세계 바이오 임플란트 시장은 몇 가지 요인에 의해 지속적으로 확대되고 있습니다. 주요 촉진요인은 전 세계적으로 고령화 인구의 증가이며, 이는 임플란트 치료가 필요한 노화 관련 질환의 발생률 증가와 상관관계가 있습니다. 동시에 심혈관질환, 근골격계 질환 등 만성질환의 유병률 증가도 수요 증가에 크게 기여하고 있습니다. 또한, 3D 프린팅 기술, 최소침습 수술 기술 등의 혁신을 포함한 생체 재료 과학과 수술 기술의 지속적인 발전은 임플란트의 효능을 높이고 적용 영역을 확장하고 있습니다.

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 바이오 임플란트 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품 유형별(심혈관용 임플란트, 척추용 임플란트, 정형외과용 임플란트, 치과 임플란트, 안과용 임플란트, 기타 임플란트)
  • 재료별(바이오소재 금속 및 합금, 세라믹, 폴리머, 기타 재료)
  • 최종사용자별(병원·진료소, 외래 수술 센터, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 바이오 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 바이오 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 바이오 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 바이오 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 바이오 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 바이오 임플란트 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• BIOTRONIK SE & Co. KG
• Invibio Limited
• Wright Medical Group N.V.
• Edwards Lifesciences Corporation
• MiMeDX Group Inc.
• Stryker Corporation
• Endo International plc
• Smith & Nephew plc
• Zimmer Biomet Holdings Inc
• Ethicon Inc.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Bio-Implants Market , valued at USD 132.24 Billion in 2024, is projected to experience a CAGR of 10.85% to reach USD 245.32 Billion by 2030. The global bio-implants market is experiencing expansion driven by several factors. A primary driver is the increasing aging global population, which correlates with a higher incidence of age-related conditions requiring implantable solutions. Concurrently, the rising prevalence of chronic diseases, such as cardiovascular and musculoskeletal disorders, significantly contributes to demand. Furthermore, continuous advancements in biomaterial science and surgical technologies, including innovations in 3D printing and minimally invasive techniques, enhance implant efficacy and expand application areas.

Key Market Drivers

The global bio-implants market is significantly driven by the expanding global aging population demographics. As life expectancy increases worldwide, the prevalence of age-related degenerative conditions requiring implantable solutions rises, including orthopedic, cardiovascular, and neurological disorders. According to the UN Department of Economic and Social Affairs, in October 2024, the global population aged 60 years and over reached 1.2 billion people, necessitating a greater demand for advanced medical interventions to maintain quality of life.

Key Market Challenges

The elevated cost associated with bio-implant procedures and devices constitutes a significant impediment to market expansion. These high costs directly impact patient access, particularly in healthcare systems where individuals bear a substantial portion of treatment expenses or where insurance coverage is limited. This financial barrier can defer or prevent necessary implant procedures, thereby constraining the potential patient pool and limiting the overall market penetration for advanced bio-implants.

Key Market Trends

The expansion of 3D printing for patient-specific implants is transforming bio-implant manufacturing by enabling the creation of custom solutions tailored precisely to individual patient anatomy. This capability improves implant fit, reduces surgical complexities, and can enhance patient recovery outcomes. The ability to produce complex geometries with accuracy using additive manufacturing methods addresses the diverse needs arising from various medical conditions. For example, Materialise, a prominent additive manufacturing company, produced over 7,000 patient-specific implants and surgical guides in 2023, demonstrating the growing practical application of this technology in clinical settings. This trend supports personalized medicine by allowing for implants that integrate seamlessly with biological structures, thereby optimizing functionality and reducing potential complications.

Key Market Players

• BIOTRONIK SE & Co. KG
• Invibio Limited
• Wright Medical Group N.V.
• Edwards Lifesciences Corporation
• MiMeDX Group Inc.
• Stryker Corporation
• Endo International plc
• Smith & Nephew plc
• Zimmer Biomet Holdings Inc
• Ethicon Inc

Report Scope:

In this report, the Global Bio-Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Implants Market, By Product Type:

• Cardiovascular Implants
• Spinal Implants
• Orthopedic Implants
• Dental Implants
• Ophthalmic Implants
• Other Implants

Bio-Implants Market, By Material:

• Biomaterial Metal & Alloys
• Ceramics
• Polymers
• Other Materials

Bio-Implants Market, By End User:

• Hospitals & Clinics
• Ambulatory Surgical Centres
• Others

Bio-Implants Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Bio-Implants Market.

Available Customizations:

Global Bio-Implants Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bio-Implants Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Cardiovascular Implants, Spinal Implants, Orthopedic Implants, Dental Implants, Ophthalmic Implants, Other Implants)
  • 5.2.2. By Material (Biomaterial Metal & Alloys, Ceramics, Polymers, Other Materials)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Bio-Implants Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Material
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bio-Implants Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Material
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Bio-Implants Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Material
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Bio-Implants Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Material
      • 6.3.3.2.3. By End User

7. Europe Bio-Implants Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Material
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bio-Implants Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Material
      • 7.3.1.2.3. By End User
  • 7.3.2. France Bio-Implants Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Material
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Bio-Implants Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Material
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Bio-Implants Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Material
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Bio-Implants Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Material
      • 7.3.5.2.3. By End User

8. Asia Pacific Bio-Implants Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Material
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bio-Implants Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Material
      • 8.3.1.2.3. By End User
  • 8.3.2. India Bio-Implants Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Material
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Bio-Implants Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Material
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Bio-Implants Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Material
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Bio-Implants Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Material
      • 8.3.5.2.3. By End User

9. Middle East & Africa Bio-Implants Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Material
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bio-Implants Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Material
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Bio-Implants Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Material
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Bio-Implants Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Material
      • 9.3.3.2.3. By End User

10. South America Bio-Implants Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Material
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bio-Implants Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Material
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Bio-Implants Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Material
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Bio-Implants Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Material
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bio-Implants Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. BIOTRONIK SE & Co. KG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Invibio Limited
• 15.3. Wright Medical Group N.V.
• 15.4. Edwards Lifesciences Corporation
• 15.5. MiMeDX Group Inc.
• 15.6. Stryker Corporation
• 15.7. Endo International plc
• 15.8. Smith & Nephew plc
• 15.9. Zimmer Biomet Holdings Inc
• 15.10. Ethicon Inc.

16. Strategic Recommendations

17. About Us & Disclaimer